Barcelona, Spain, and Cambridge, United States – April 28th – Pharmacelera, the leading provider of advanced computational tools for drug discovery, and
Barcelona, Spain, and Kyiv, Ukraine – March 3, 2026 – Pharmacelera, the deeptech company pushing the limits of computational technologies for drug
Boston and Barcelona — February 23, 2026 — Pharmacelera, a deep-tech company developing and applying high-accuracy Quantum Mechanics and Artificial Intelligence (“deep
Round led by Heran Partners and joined by Clave Capital, Inveready and Bio&Tech Smart Capital Financing will enable Pharmacelera to build ongoing
California, US & Barcelona, Spain — October 13th, 2025 — Together with eMolecules we announce the launch of a new integrated solution combining ExaScreen® with
Cambridge, UK & Barcelona, Spain — August 27th, 2025 — Domainex, a leading integrated drug discovery services company, and Pharmacelera, a pioneer
We are thrilled to announce a collaboration between Pharmacelera and the UMass Chan Medical School aimed to support early-stage drug discovery projects.
In our latest paper published in the Journal of Chemical Information and Modeling (JCIM) by the American Chemical Society, we introduce two
We’re excited to announce the release of Pharmacelera’s 2025.01 software update! What’s New in 2025.01? 🔹 Custom Ultra-Large Library Generation
By Nicola Scafuri and Ana Caballero A larger number of ligands in the virtual screening library increases the chances of identifying ligands
By Carlos Cruz and Ana Caballero The success of a ligand-based virtual screening campaign relies on their molecular descriptors, in this sense,
By Tiziana Ginex and Fernando Martin The ever-increasing accessible chemical space opens the door to the search for new chemical matter for
Barcelona, Leiden and Uppsala, July 2nd 2024 – Pharmacelera, the leading provider of computational tools for hit discovery, the Leiden Academic Center
San Diego and Barcelona. May 21st 2024. Pharmacelera, a deep tech company that develops and applies accurate Quantum Mechanics and Artificial Intelligence
Barcelona, Spain, and Kyiv, Ukraine, 07 May 2024. Pharmacelera, the leading provider of computational tools for hit discovery, and Enamine, the developer
The application of ligand-based virtual screening (LBVS) is commonly extended in the screening of vast chemical libraries to find novel chemical matter
